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Procuring organs for transplantation
A European perspective
GURCH RANDHAWA *
Background: The shortage of organs for transplant in Europe has been considerable for many years. A number of
different policies have been implemented in an attempt to address this problem. These have had varying degrees of
success from country to country. Methods: This article provides an up-to-date review of organ procurement policies
throughout Europe. Alternative and in some cases controversial organ procurement programmes are also considered
to establish whether the increasing demand for organs can be met elsewhere. Results: Transplant watting lists are
the greatest by far for those patients waiting for a kidney replacement Norway has best managed to address this
need through adopting a positive policy choice towards live donation whilst still maintaining an active cadaveric
donation policy. Conclusion: With the lowering of both physical and social barriers in Europe, there has been a recent
shift towards co-operation between some European countries in promoting transplant activity. This ensures that rf
an organ becomes available in one country and has no suitable recipient, then it can be used elsewhere. The future
may show and increasing trend towards this level of European cooperation in order to make transplant activity more
efficient
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T
A he purpose of this paper is to provide an up-to-date
review of the current status of frequently changing public
policies in Europe for the procurement of donor organs
for transplantation. This paper consists of two main parts:
firstly, an outline of European transplant activity and,
secondly, an assessment of the different public policies
pertaining to transplant activity. This will also include a
discussion of the implications for introducing new and
possibly controversial policies related to procuring in-
creased numbers of organs.
In Europe, there is currently a crisis over the supply of
organs for transplant; this supply is increasingly unable to
meet the growing demand.1'2 The most recent and
worrying statistics show that throughout the European
region (this includes the following transplant-active
countries: Austria, Belgium, Denmark, Finland, France,
Germany, Greece, The Netherlands, Hungary, Italy,
Norway, Portugal, Spain, Sweden, Switzerland and the
UK) the numbers waiting for a kidney transplant had
reached almost 40,000 by the end of 1994, with the gap
between those waiting and those receiving a transplant
growing wider.2 This pattern is also mirrored for other
major organs such as the heart, lung and liver in the
European region as well as worldwide. For organs such as
the heart, pancreas, liver and lung, successful donation is
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only possible from dead donors (cadaveric donation).
This is not the case for the kidney, however, where it is
possible for a person to donate a kidney while alive and
still lead an active and healthy life with the one remaining
kidney. Thus, there are two major sources of organ
procurement for the kidney, either cadaveric or living
donors.
This article will focus upon the kidney since this is where
the problem is greatest because of the increasing number
of patients now recognized as requiring and likely to
benefit from renal replacement therapy. Since kidney
transplantation is the longest established and most widely
practised of the transplant operations, international data
are the most complete and reliably available.1 Unfortu-
nately, equivalent data is not widely available for other
organs. It may be noted, however, that much of the
discussion related to procuring kidneys from cadaveric
donors can be applied to the other major organs and these
links will be highlighted where appropriate.
EUROPEAN TRANSPLANT ACTIVITY
This section deals with cadaveric and live kidney trans-
plantation rates in Europe for the year ending 1994- A
note of caution should be added at this point about the
interpretation of results as these rates will depend on the
particular circumstances prevailing during a particular
year. The figures presented, however, do highlight trends
and patterns of transplant activity. Countries ranked by
their 1994 cadaveric kidney transplantation rate are
shown in figure I. Austria, Spain, Belgium, Finland and
Portugal show markedly higher transplantation rates than
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the other European coun-
tries ranging from 34.9 per
million population (pmp) for
Portugal to 42.2 pmp for
Austria. There then follows
a cluster of countries which
have broadly similar trans-
plantation rates ranging
from 23.4 pmp for Hungary
to 30.2 pmp in Switzerland.
The remaining countries,
Italy, Luxembourg and
Greece in particular, have
much lower rates of
cadaveric transplantation.
This can be partly explained
by their more recent in-
volvement with transplant
technology.
Live donation also varies
significantly throughout
Europe, as shown in figure 2,
but, with the exception of
Finland, the Scandinavian
countries appear to have
been particularly successful
in procuring kidneys. Nor-
way has by far the highest
rate, with 17.7 pmp. Others,
including the five leading
cadaveric transplant coun-
tries, undertake relatively
few. Portugal, for example,
conducts no live transplants
at all. A pattern emerges
here in that the more suc-
cessful a country appears to
be at procuring cadaver or-
gans the less likely it is to
undertake live transplants
and vice versa.
Upon analysing the total
number of kidney trans-
plants undertaken and the
proportion of this total made
up by live transplants, one
can see that Norway has the
greatest with 44-5 pmp
(figure 3). Switzerland per-
forms a large number of
cadaveric transplants yet
also has a modest live donor
programme, both contrib-
uting to the high total num-
ber of grafts. Many of the
countries low in the league
table, with the exception of
Greece, use few live dona-
tions. However, Austria and
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Figure 1 Cadavenc kidney transplantanon rates (pmp) in Europe's leading transplant countnes, 1994
Source: Council of Europe Transplant Newsletter, March 1996
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Figure 2 Live kidney transplantation rates (pmp) in Europe's leading transplant countries, 1994
Source: Council of Europe Transplant Newsletter, March 1996
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Figure 3 Total kidney transplantation rates (cadaveric plus live) (pmp) and the proportion
of live transplants, 1994
Source: Council of Europe Transplant Newsletter, 1996
[ % ]: Live transplants as a proportion of total
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Spain, two of the three countries achieving the highest
number of grafts, carry out few live donations.
The data presented above highlight the current status of
transplant activity in the major transplant-active coun-
tries of Europe. This paper now goes on to investigate the
various public policies in these countries relating to organ
procurement to establish whether there are successful
policies operating in certain countries which may be
worth considering for those countries who as yet have
been relatively unsuccessful in procuring organs.
It must be stressed that organ procurement policies are not
the sole influence on transplantation rates. Other in-
fluential factors include death rates from relevant causes,
the demographic and physical characteristics of a country,
level of health care funding and cultural factors.1
However, policies can at least be implemented and
adapted by the relevant authorities depending on the
transplant situation.
ORGAN PROCUREMENT PROGRAMMES IN EUROPE
Cadaveric donation
The countries of Europe can be categorized according to
their adoption of one of two types of organ procurement
programme. These might be broadly termed as the
'opting-in' and 'presumed consent/opting-out' legal sys-
tems. Opting-in relies upon voluntarism and is mainly
operated with the use of donor cards or donor registers.
Opting-out, on the other hand, is a scheme where consent
to organ donation is presumed unless a person has ex-
pressly refused permission by signing on an opting-out
register.-3 Fundamentally, in an opting-in scheme what
individuals register is a wish to donate, whilst in an
opting-out scheme what is registered is a refusal to parti-
cipate.
Table 1 Cadaveric kidney transplantation rates (pmp) in Europe's
leading transplant countries, 1994
Austria
Spain
Belgium
Finland
Portugal *
Switzerland
United Kingdom
Sweden
Norway
Denmark
The Netherlands
France
Germany
Hungary
Italy
Luxembourg
Greece
pmp
42.2
42.0
37.4
35.0
43.9
30.2
28.8
27.5
26.8
25.8
25.8
24.7
23.7
23.4
14.8
10.0
4.6
Opting-out legislation
Yes
Yes
Yes
Yes
Yes
Yes
Yes
a: Opiing-out legislation in Portugal was introduced in 1994
Examining the ranking of die European countries accord-
ing to dieir cadaveric kidney transplantation rates and the
legal system in operation (table I) shows that presumed
consent may indeed be an important factor in increasing
donation rates. The leading five countries each has some
form of presumed consent legislation. Analysis of the
effect of introducing an opting-out law has been con-
sidered previously and it has been demonstrated that it
has a positive impact on the number of available organs
in Austria, Belgium, and Singapore.1'4
The two public policies, however, are fundamentally
based on different ethical and social values. Any legis-
lation veering towards one or the other would need to deal
with these issues both at the government and public level.
Opting-in
The opting-in system is in use in many countries and is
facilitated by people carrying a donor card or signing on
a organ donor register. For this system to have a direct
impact on procurement rates either a donor card must be
found on the body of the deceased at or shortly after the
time of death or the deceased person's name should be on
the donor register. Even so, in the UK and in some other
European countries, it is usual to obtain the consent of
the next-of-kin in addition, if this can be done in time for
the organs to be viable.
As an indirect way of raising public awareness the impact
of the card and register cannot be overestimated.1>3 In
several countries, national publicity campaigns have been
used to increase the uptake of donor cards and ultimately
increase donation rates. One example of their potential
influence can be seen in the 42% increase in the number
of kidney donations in Britain in 1984 which coincided
with a 6 month campaign conducted by the Department
of Health and Social Security using television and news-
paper advertising to describe the donor card system.5 Such
publicity can affect card carrying directly and can also
have indirect effects on donation by initiating debate and
increasing awareness.3
Efforts such as these are highly commendable but have
done little to address the underlying problem which is to
achieve card carrying or signing on the donor register
amongst those members of the public whose families
would otherwise have refused consent.1 This can only be
tackled through concerted education campaigns, using
various forms of media to highlight the benefits of trans-
plantation and appeal to the public's sense of altruism.
Presumed consent
A presumed consent law presumes that an individual has
consented to organ donation at the time of death unless
there is contrary documentary evidence or, in some coun-
tries, objections by die family. Assuming that the com-
mitment of society were strong towards donation and that
die public trusted die concept and application of brain
deadi, diis system should dieoretically reduce die donor
shortage drastically. The positive impact on trans-
plantation rates is visible in table I, but there are moral
issues to consider in implementing such a policy.
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Presumed consent schemes have been introduced into
many European countries (Austria, Belgium, Finland,
France, Italy, Norway, Spain, and Sweden). The argu-
ments in favour of presumed consent are based on die
presumption that diere will be a marked reduction in
transplant waiting lists. It is argued diat such a statute
could be introduced whilst giving people die opportunity
to opt-out on religious or moral grounds.7 This is die case
in Singapore where a presumed consent system is in
operation but excludes all Muslim citizens as diey prefer
to exercise die right of opting-in.^
The arguments against presumed consent are that only
the educated and more advantaged groups in society are
able to exercise informed choice and act autonomously in
such a scheme and the situation can arise where die poor
and uneducated would not have die same autonomy due
to lack of knowledge. We could also reach the stage where
patients close to deadi would be looked upon solely as a
source of organs.7
Live donation
Live donation legislation has been introduced throughout
Europe and implemented with varying degrees of success.
The principal source of live donations is from those who
are both genetically similar and related to die recipient
but sometimes donors are those who are not genetically
similar but are related (spouses) and, in special circum-
stances, donors who are genetically similar but unrelated
to the recipient. Strict regulations have been imple-
mented to control the latter type of donation to reduce
die possibility of non-voluntary donors.
It is evident from the figures on European transplant
activity that Norway has pursued a live donation policy
more actively dian its counterparts in Europe. The main
reason for diis is its low population density: there are
organizational implications for transplantation activity
attached to a small population living in a large country.
Norway is constrained by the fact diat it has only one
transplant centre in Oslo. This has had a major influence
on die low rate of cadaveric transplant activity due to the
large distances between die donor hospitals and the trans-
plant centre. Thus, die live donor alternative is a much
more appealing proposition and is pro-actively pursued as
a procurement option.
The Norwegian programme involves exploring die pos-
sibility of live donation as soon as die decision for trans-
plant is taken. Family members are assessed for suitability
and the possibility of live donation is discussed where
transplantation is feasible. The act of donation must be
demonstrably voluntary and, if there appears to be any
signs of coercion or feelings of obligation, die physician
will declare the potential donor medically ineligible for
donation dius relieving die family member of any res-
ponsibility for making such a decision. This also serves to
dispel any doubts or suspicion on die part of other family
members of the donor's willingness to take part.8
For those patients waiting for a kidney transplant, the
time and financial and emotional costs of travelling to
9 and from the dialysis centre two or three times a week are
extremely heavy. '° This is true for all patients regardless
of their country of residence. Taking a pro-active ap-
proach to live donation has been shown to be an import-
ant determinant in increasing procurement rates since the
number of live transplants performed in Finland, anodier
country with a low population density but a less-organized
approach to live donation, is far fewer.
As is the case widi all odier forms of transplant policy,
live donation raises a number of ethical concerns. Firstly,
there is the issue diat live donation is a procedure diat
may not be in die medical interests of the donor. As such,
it is a practice which runs counter to the medical profes-
sion's code of ediics. However, what needs to be balanced
are, on die one hand, the medical benefits to die recipient
and die emotional benefit to die donor, who is in most
cases die recipient's close relative and, on die other, the
minimal but nevertheless real risk to the donor of invasive
surgery.10
A final concern is that diere may be financial induce-
ments offered to persuade people to donate organs. This
relates more specifically to unrelated donors. Measures
have been taken to outlaw diis procedure in Europe and
diroughout the rest of the world by introducing statutes
prohibiting trading in human organs such as the Human
Organ Transplants Act (1989) in die UK.7 However, this
practice is very difficult to monitor, particularly in the
case of intrafamily exploitation.
Future alternatives
Elective ventilation
Traditionally, die intensive care unit (ICU) has been die
main source for organ donation as die vast majority of
donors are diose who have sustained some form of fatal
head injury, normally as a result of a road accident or those
patients who have suffered a cerebrovascular accident
(stroke). However, there is a supply of potential organ
donors in general wards which has been previously over-
looked: patients at risk of suffering a cerebrovascular
accident while on die ward. If these patients were identi-
fied and subsequently transferred to the ICU, they could
be artificially ventilated to preserve the organs until
brainstem death can be established.
Clearly there are ethical concerns with such an initiative.
Elective ventilation is not in die interests of die patient
but of die organ recipient. For such practice to conform
to legal statutes, patient consent would be required yet
diis is not possible as the donor would be in coma before
ventilation was even considered.1 A recent report by the
British Transplant Society has recommended legislation
to overcome these concerns.11'
A protocol for electively ventilating patients has been
developed in Exeter, UK. This has proved to be highly
successful, inasmuch as initial predictions show an in-
crease in donors of 50%. ^  Large-scale clinical trials are
planned in order to evaluate die wider potential of
elective ventilation effectively. A rigorous ethical proto-
col that addresses die above issues will need to be in place
before such an initiative could commence.
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Non-heart-beating donors
As stated earlier, the vast majority of cadaveric donors die
as a result of cerebrovascular accidents and fatal head
injuries, where brain death has been established. With
advances in medical technology, another potential source
of organ donors has been identified in those patients who
have suffered a fatal cardiac arrest and where brain death
is inevitable and irreversible. It is possible to harvest the
kidneys of patients in diese circumstances.14
This procedure would operate if cardiac arrest has oc-
curred. The kidneys would then be protected by cold
perfusion until family consent for organ donation could
be established. Cold perfusion involves inserting an ir-
rigation tube into the non-heart beating donor.14 Pilot
clinical trials of this procedure have been undertaken
under the strict supervision of medical authorities and the
consent of relatives in The Netherlands and Leicester,
UK. The initial results are very promising showing an
increase in the number of kidney transplants by 21 % over
a nine year period in The Netherlands and 38% over a
one year period in Leicester.14"
Even if clinical trials are evaluated successfully, an ethical
point of concern remains with this procedure. Performing
invasive surgery in order to insert the irrigation tube into
the dying patient before consent has been established can
be viewed as an act undertaken solely for the purpose of
procuring organs which is not in the interests of die
patient.1 This could lead to further ethical and legal
problems if consent is refused and the patient's relatives
react adversely towards the surgery.
Xenotransplanwaon
The most recent and radical solution to reduce the scar-
city in organs is the development of xenotransplantation,
the use of animal organs for transplantation into humans.
Research is being carried out in Cambridge, UK, where it
is hoped the strong human immunological response to
foreign tissue can be overcome by using organs from
genetically altered pigs. The idea is to trick the human
immunological response into thinking the pig's heart is
its own.1'
Clearly, xenotransplantation is controversial and raises a
number of concerns. The risk of a variety of diseases
spreading into humans coupled with die ethical problems
of using animal organs suggests diat further consideration
should be given to alternative organ procurement pro-
grammes.18 This is die stance recently adopted by the
Department of Health's Advisory Group on the Ediics of
Xenotransplantation in the UK.19
DISCUSSION
A review of transplant activity in Europe and relevant
public policies shows diat all methods of organ procure-
ment entail bodi organizational and ediical problems. For
example, pursuing a live donation programme more
vigorously dian cadaveric donation has obvious reper-
cussions for the types of organs procured. The number of
kidneys obtained will clearly be much greater but there
will be a correspondingly lower number of hearts, lungs,
livers and pancreases procured. If demand for these organs
increases, then countries may be forced to adopt a more
aggressive approach towards cadaveric donation.
One cannot overlook, however, the extent to which die
success of organ procurement programmes in some coun-
tries, particularly Norway, depends on an active live
donation policy. The main proviso is diat such an initi-
ative requires close monitoring to ensure that die donor
is acting voluntarily and that there is no sign of coercion
or exploitation. Given the increased recognition diat
end-stage renal failure in older patients and diabetics can
be effectively treated, kidneys are currently die organ in
greatest demand. Live donation offers the best possible
hope of procuring a suitable kidney donor quickly. A
positive policy choice, as implemented in Norway, is a
policy to which other European countries should give
serious consideration. Simply enacting legislation to
make live donation permissible is not enough.
Ideally, each country should have an active cadaveric
donation programme running in parallel with live dona-
tion arrangements. The problem lies in identifying the
most suitable cadaveric programme to implement since
none is without its limitations.3 Donor card holders may
not be identified either because the card is not found or,
in some cases, is not looked for. The family of the deceased
may conceal die existence of the card and the operation
of a veto by relatives may frustrate a genuine desire on the
part of die deceased to become a donor. Similar problems
may occur in identifying patients who are on the donor
register as quick and accurate access to the register is
required by all hospitals involved with the trans-
plantation.3
Obtaining consent from the patient's relatives is an integ-
ral part of the process of voluntary donation. However,
research has shown that many medical staff find it very
difficult to make such an approach. There is no doubt
that die most important determinant of the frequency of
organ donation is the willingness of die medical and
nursing staff caring for potential donors to initiate this
process and to undertake die considerable extra work it
entails.22 Training programmes for medical staff diat ad-
dress the highly sensitive issue of dealing with bereaved
relatives and making a request for organs are essential.23
The opting-out or presumed consent policy operates in
the five countnes with the highest cadaveric transplant
rates. The danger is that a presumed consent protocol may
run counter to an individual's and/or relatives' beliefs yet
be in operation before this becomes known. This is a risk
which is particularly likely to affect those who are least
well-equipped to make an informed choice about opting-
out ."
Future interventions for procuring organs such as elective
ventilation and xenotransplantation also raise ethical
concerns. There is no doubt diat if appropriate measures
were taken the supply of organs through existing pro-
grammes could be markedly increased. Xenotransplanta-
tion in Europe or any odier part of die world for diat
matter should not go ahead until the existing national
organ procurement programmes are reviewed and die
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possibility of introducing other human organ procure-
ment programmes which are used currently in some other
countries is explored.18
CONCLUSION
The way forward seems clear; adopting a positive ap-
proach towards live donation whilst maintaining an
active cadaveric programme. No matter which type of
organ procurement policy is implemented, measures need
to be taken to attract more donors. This may be achieved
through sustained awareness-raising and education cam-
paigns for both die public and health professionals.' ^ The
benefits of and procedures involved in organ donation
and transplantation are key messages to deliver. If diere
was a move to change procurement arrangements in some
countries, dien new laws and regulations would be re-
quired. These in turn would require mass information
campaigns to ensure they were accepted by the general
public and enacted by politicians.
The success of such initiatives would see a marked in-
crease in die number of transplants performed and
diereby a reduction in transplant waiting lists. Given diat
die cost of a transplant is lower dian maintaining a patient
on dialysis, diere are clear long-term economic benefits
for national healdi services in promoting transplantation
activity, with millions of pounds saved each year. As a
general rule, die cost of a successful transplant plus one
year of post-operative dierapy amounts to less dian die
cost of one year of the cheapest form of chronic dialysis.
After die first year of post-operative dierapy, die costs are
much lower dian annual dialysis.24
Widi die desperate shortage of organs clearly apparent
throughout many European countries diere has been a
shift towards cooperation between countries in order to
attempt to alleviate the problem. Eurotransplant and
Scandiatransplant are examples of such organizations
where countries are jointly promoting and organizing
transplant activity. (Eurotransplant covers Austria, Bel-
gium, Germany, Luxembourg, and The Netherlands,
while Scandiatransplant covers Denmark, Finland, Nor-
way and Sweden). This ensures that organs which have
become available in one country but have no suitable
recipient can be used elsewhere. Thus, resources are saved
and transplant activity is becoming increasingly efficient.
It is hoped diat odier countries will follow this initiative
and form trans-European healdi policy alliances.
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